🇦🇹 Austria Country × Condition
acute myeloid leukemia Clinical Trials in Austria
Active clinical trials for acute myeloid leukemia with research sites in Austria. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 3 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇦🇹 Austria
Active Trials in Austria (2)
NCT07075016 Phase 3
Recruiting
Ivosidenib and Azacitidine With or Without Venetoclax in Adult Patients With Newly Diagnosed IDH1-Mutated AML or MDS/AML Considered Ineligible for Intensive Chemotherapy
Enrollment
227 pts
Country
🇦🇹 Austria
Stichting Hemato-Oncologie voor Vol...
View Trial → NCT05183035 Phase 3
Recruiting
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Enrollment
130 pts
Country
🇦🇹 Austria
PedAL BCU, LLC
View Trial → Frequently Asked Questions
How many acute myeloid leukemia clinical trials are active in Austria?
There are currently 2 active clinical trials for acute myeloid leukemia with sites in Austria, of which 2 are actively recruiting patients.
How can I join a acute myeloid leukemia clinical trial in Austria?
To join a acute myeloid leukemia clinical trial in Austria, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Austria directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are acute myeloid leukemia trials in Austria?
Active acute myeloid leukemia trials in Austria span Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology